Search Results - Chowaniecova, G

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    EGFR mutations in squamous NSCLC – Prevalence and treatment results with EGFR tyrosine kinase inhibitors (TKIs) in patients from western Slovakia

    EGFR mutations in squamous NSCLC – Prevalence and treatment results with EGFR tyrosine kinase inhibitors (TKIs) in patients from western Slovakia by Berzinec, P, Hlinkova, K, Copakova, L, Konecny, M, Zavodna, K, Cerna, M, Culagova, M, Chowaniecova, G, Babal, P

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

    P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study by Berzinec, P., Kasan, P., Mazal, J., Andrasina, I., Cipkova, A., Chowaniecova, G., Martak, M., Urda, M., Vesela, M., Plank, L.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    EP1.14-34 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study

    EP1.14-34 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study by Berzinec, P., Kasan, P., Mazal, J., Andrasina, I., Cipkova, A., Chowaniecova, G., Martak, M., Urda, M., Vesela, M., Jancokova, I., Kuliskova, I., Plank, L.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    EP1.04-19 First Experience with Atezolizumab in Slovakia

    EP1.04-19 First Experience with Atezolizumab in Slovakia by Kasan, P., Berzinec, P., Cerna, M., Andrasina, I., Cipkova, A., Chowaniecova, G., Denkova, L., Godal, R., Kuzmova, H., Svihelova – Liskova, Z., Martak, M., Mazal, J., Obertova, J., Pribulova, Z., Urda, M., Vesela, M.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    P2.03-056 Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakiab NSCLC Patients - Updated Survival Data

    P2.03-056 Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakiab NSCLC Patients - Updated Survival Data by Berzinec, P., Kasan, P., Godal, R., Plank, L., Copakova, L., Alemayehu, A., Chowaniecova, G., Farkasova, A., Hlavcak, P., Kucma, M., Rotikova, L., Slavikova, M., Vasovcak, P.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study: EP1.14-34

    Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study: EP1.14-34 by Berzinec, P, Kasan, P, Mazal, J, Andrasina, I, Cipkova, A, Chowaniecova, G, Martak, M, Urda, M, Vesela, M, Jancokova, I, Kuliskova, I, Plank, L

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    First Experience with Atezolizumab in Slovakia: EP1.04-19

    First Experience with Atezolizumab in Slovakia: EP1.04-19 by Kasan, P, Berzinec, P, Cerna, M, Andrasina, I, Cipkova, A, Chowaniecova, G, Denkova, L, Godal, R, Kuzmova, H, Svihelova – Liskova, Svihelova Z, Martak, M, Mazal, J, Obertova, J, Pribulova, Z, Urda, M, Vesela, M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: